查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790365

美国抗生物膜伤口敷料市场规模、份额和趋势分析报告：按机制、应用、最终用途、地区和细分市场预测，2025-2030 年

U.S. Anti-biofilm Wound Dressing Market Size, Share & Trends Analysis Report By Mode of Mechanism (Physical, Chemical, Biological), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

美国抗生物膜伤口敷料市场概况

2024 年美国抗生物膜伤口敷料市场规模为 3.142 亿美元，预计到 2030 年将达到 5.463 亿美元，2025 年至 2030 年的复合年增长率为 9.8%。市场成长归因于糖尿病、癌症、心血管疾病和其他自体免疫疾病等慢性疾病的增加导致慢性和急性伤口的盛行率不断上升。

根据美国疾病管制与预防中心的数据，截至 2021 年，超过 3,800 万人（占美国总人口的 11% 以上）患有糖尿病。美国道路交通事故数量的增加极大地促进了市场的成长。根据美国运输部的数据，到 2024 年，将有超过 39,000 人死于道路交通事故。道路交通事故的增加推动了对具有抗生物膜特性的创伤护理产品的需求，因为这些事故可能导致严重烧烫伤和创伤。政府和私人部门不断增加对先进创伤护理技术的投资，以改善患者治疗效果并降低医疗保健成本，这进一步促进了市场的成长。

法律规范确保安全性和有效性，促进先进抗菌敷料的采用，而最终用途集中凸显了医院、专科诊所和门诊诊所等关键医疗保健部门对推动需求的重要性。

创新依然至关重要，因为各公司都在大力投入研发，以开发具有增强抗生物膜功能的敷料。 2025年4月，康维泰克宣布计划首次推出其新技术ConvaNiox，利用强效抗菌和抗生物膜剂一氧化氮。 ConvaNiox最初将用于治疗糖尿病足溃疡 (DFU)，并已被证明与标准治疗相比，其伤口面积减少速度加快三倍，DFU癒合率提高60%。

糖尿病盛行率的上升，加上人口老化，进一步推动了需求成长。製造商纷纷提高产量，拓展产品线，以满足此细分市场的独特需求。例如，许多公司正在扩大其在美国的生产能力，并加强分销网络，以便更好地服务医疗保健机构。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国抗生物膜伤口敷料市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关市场展望
  • 产业价值链分析
  • 法律规范
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战
    • 行业机会
  • 产业分析工具
    • 波特五力分析

第四章美国抗生物膜伤口敷料市场：机制、估算与趋势分析

  • 细分仪表板
  • 美国抗生物膜伤口敷料市场：机制变异分析和市场占有率（2024 年和 2030 年）
  • 身体的
    • 手动清创
    • 脉衝电场
    • 超音波清创
  • 化学品
    • 离子银
    • 碘
    • EDTA
    • 其他的
  • 生物
    • 分散素B
    • 乳铁蛋白
    • 噬菌体
    • 其他的

第五章美国抗生物膜伤口敷料市场：应用、预测与趋势分析

  • 细分仪表板
  • 美国抗生物膜伤口敷料市场：应用变化分析和市场占有率（2024 年和 2030 年）
  • 慢性伤口
    • 糖尿病足溃疡
    • 压疮
    • 静脉性腿部溃疡
    • 其他的
  • 急性伤口
    • 外科性创伤与创伤伤口
    • 烧烫伤

第六章。美国抗生物膜伤口敷料市场（按最终用途、估计和趋势分析）

  • 细分仪表板
  • 美国抗生物膜伤口敷料市场：2024 年和 2030 年最终用途变化分析和市场占有率
  • 医院
  • 专科诊所
  • 家庭医疗保健
  • 其他的

第七章美国抗生物膜伤口敷料市场竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图
  • 2024年排名分析
  • 战略地图
    • 扩张
    • 合併与收购
    • 伙伴关係和合作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • ConvaTec Inc.
    • Smith & Nephew PLC
    • Imbed Biosciences
    • Next Science
    • B. Braun Melsungen AG
    • 3M
    • Molnlycke Health Care AB
    • Coloplast
    • Lohmann & Rauscher
Product Code: GVR-4-68040-666-0

U.S. Anti-Biofilm Wound Dressing Market Summary

The U.S. anti-biofilm wound dressing market size was valued at USD 314.2 million in 2024 and is projected to reach USD 546.3 million by 2030, growing at a CAGR of 9.8% from 2025 to 2030. The market's growth can be attributed to the growing prevalence of chronic and acute wounds owing to the increase in chronic diseases, including diabetes, cancer, cardiovascular diseases, and other autoimmune diseases.

According to the U.S. Centers for Disease Control and Prevention, as of 2021, over 38 million people, over 11% of the overall U.S. population, had diabetes. The country's increasing number of road accidents significantly contributes to the market's growth. According to the U.S. Department of Transportation's National Highway Traffic Safety Administration, over 39,000 people died in road accidents in 2024. The growing number of road accidents increases the demand for wound care products with anti-biofilm properties, as these accidents can lead to severe burns and traumatic injuries. The increasing government and private investments in advanced wound care technologies to improve patient outcomes and lower healthcare costs further contribute to the market's growth.

Regulatory frameworks ensure safety and efficacy and promote the adoption of advanced antimicrobial dressings, while end-use concentration highlights the significance of key healthcare segments such as hospitals, specialty clinics, and outpatient clinics in driving demand.

Innovation remains crucial as companies invest heavily in R&D to develop dressings with enhanced anti-biofilm capabilities. In April 2025, Convatec announced its plans for the initial market launch of ConvaNiox, a new technology powered by a potent antimicrobial and antibiofilm agent, nitric oxide, which is supported by strong clinical evidence. ConvaNiox will be initially used for the management of diabetic foot ulcers (DFUs), which has been demonstrated to reduce the wound area three times faster and increase DFU healing by 60% in comparison to the standard of care.

The rising incidence of diabetes, alongside an aging demographic, further increases the demand, urging manufacturers to increase production and broaden their product ranges to cater to the sector's specific requirements. For instance, numerous companies have enhanced their manufacturing capabilities within the U. S. and fortified their distribution networks to serve healthcare providers better.

U.S. Anti-biofilm Wound Dressing Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. anti-biofilm wound dressing market report based on mode of mechanism, application, and end-use:

  • Mode of Mechanism (Revenue, USD Million, 2018 - 2030)
  • Physical
    • Manual Debridement
    • Pulse Electrical Field
    • Ultrasound Debridement
  • Chemical
    • Ionic Silver
    • Iodine
    • EDTA
    • Others
  • Biological
    • Dispersin B
    • Lactoferrin
    • Bacteriophage
    • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Others
  • Acute Wounds
    • Surgical & Traumatic Wounds
    • Burn Wounds
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Anti-biofilm Wound Dressing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenges
    • 3.4.4. Industry Opportunities
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis

Chapter 4. U.S. Anti-biofilm Wound Dressing Market: Mode of Mechanism Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Anti-biofilm Wound Dressing Market: Mode of Mechanism Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Physical
    • 4.3.1. Physical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Manual Debridement
      • 4.3.2.1. Manual Debridement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Pulse Electrical Field
      • 4.3.3.1. Pulse Electrical Field Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Ultrasound Debridement
      • 4.3.4.1. Ultrasound Debridement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Chemical
    • 4.4.1. Chemical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Ionic Silver
      • 4.4.2.1. Ionic Silver Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Iodine
      • 4.4.3.1. Iodine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. EDTA
      • 4.4.4.1. EDTA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Biological
    • 4.5.1. Biological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Dispersin B
      • 4.5.2.1. Disperin B Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Lactoferrin
      • 4.5.3.1. Lactoferrin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Bacteriophage
      • 4.5.4.1. Bacteriophage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Anti-biofilm Wound Dressing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Anti-biofilm Wound Dressing Market: Application Movement Analysis & Market Share, 2024 & 2030
  • 5.3. Chronic Wounds
    • 5.3.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Diabetic Foot Ulcers
      • 5.3.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Pressure Ulcers
      • 5.3.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Venous Leg Ulcers
      • 5.3.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Others
      • 5.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Acute Wounds
    • 5.4.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Surgical & Traumatic Wounds
      • 5.4.2.1. Surgical & Traumatic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Burn Wounds
      • 5.4.3.1. Burn Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Anti-biofilm Wound Dressing Market: End-Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Anti-biofilm Wound Dressing Market: End-Use Movement Analysis & Market Share, 2024 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Specialty Clinics
    • 6.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Home Healthcare
    • 6.5.1. Specialty Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Anti-biofilm Wound Dressing Market - Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map
  • 7.4. Position Analysis, 2024
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Product Launches
    • 7.5.5. Research and Development
  • 7.6. Company Profiles
    • 7.6.1. ConvaTec Inc.
      • 7.6.1.1. Participant's overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Recent developments
    • 7.6.2. Smith & Nephew PLC
      • 7.6.2.1. Participant's overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Recent developments
    • 7.6.3. Imbed Biosciences
      • 7.6.3.1. Participant's overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Recent developments
    • 7.6.4. Next Science
      • 7.6.4.1. Participant's overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Recent developments
    • 7.6.5. B. Braun Melsungen AG
      • 7.6.5.1. Participant's overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Recent developments
    • 7.6.6. 3M
      • 7.6.6.1. Participant's overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Recent developments
    • 7.6.7. Molnlycke Health Care AB
      • 7.6.7.1. Participant's overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Recent developments
    • 7.6.8. Coloplast
      • 7.6.8.1. Participant's overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Recent developments
    • 7.6.9. Lohmann & Rauscher
      • 7.6.9.1. Participant's overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Recent developments

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. anti-biofilm wound dressing market 2018 - 2030 (USD Million)
  • Table 3 U.S. anti-biofilm wound dressing market estimates and forecasts by mode of mechanism 2018 - 2030 (USD Million)
  • Table 4 U.S. anti-biofilm wound dressing market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. anti-biofilm wound dressing market estimates and forecasts by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 QFD Modeling for Market Share Assessment
  • Fig. 6 Information Procurement
  • Fig. 7 Market Formulation and Validation
  • Fig. 8 Data Validating & Publishing
  • Fig. 9 Market Segmentation & Scope
  • Fig. 10 U.S. Anti-biofilm Wound Dressing Market Snapshot
  • Fig. 11 Segment Snapshot (1/2)
  • Fig. 12 Segment Snapshot (1/2)
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook
  • Fig. 15 U.S. Anti-biofilm Wound Dressing Market Value, 2024 (USD Million)
  • Fig. 16 U.S. Anti-biofilm Wound Dressing Market - Value Chain Analysis
  • Fig. 17 U.S. Anti-biofilm Wound Dressing Market - Market Dynamics
  • Fig. 18 U.S. Anti-biofilm Wound Dressing Market - PORTER's Analysis
  • Fig. 19 U.S. Anti-biofilm Wound Dressing Market - PESTEL Analysis
  • Fig. 20 U.S. Anti-biofilm Wound Dressing Market Estimates & Forecasts, by Mode of Mechanism: Key Takeaways
  • Fig. 21 U.S. Anti-biofilm Wound Dressing Market Share, by Mode of Mechanism, 2024 & 2030
  • Fig. 22 Physical Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Manual Debridement Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Pulse Electrical Field Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Ultrasound Debridement Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Chemical Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Ionic Silver Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Iodine Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 EDTA Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Biological Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Dispersin B Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Lactoferrin Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Bacteriophage Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Anti-biofilm Wound Dressing Market Estimates & Forecasts, by Application: Key Takeaways
  • Fig. 37 Chronic Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Diabetic Foot Ulcers Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Pressure Ulcers Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Venous Leg Ulcers Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Acute Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Surgical & Traumatic Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Burn Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Anti-biofilm Wound Dressing Market Estimates & Forecasts, by End-Use: Key Takeaways
  • Fig. 46 Hospitals Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Specialty Clinics Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Home Healthcare Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key Company Categorization
  • Fig. 51 Company Market Positioning
  • Fig. 52 Strategy Mapping